Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Moyamoya disease: diagnosis and interventions
M Ihara, Y Yamamoto, Y Hattori, W Liu… - The Lancet …, 2022 - thelancet.com
Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive
stenosis of the terminal portion of the internal carotid arteries and compensatory capillary …
stenosis of the terminal portion of the internal carotid arteries and compensatory capillary …
The genetic basis of moyamoya disease
R Mertens, M Graupera, H Gerhardt, A Bersano… - Translational stroke …, 2022 - Springer
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
spontaneous bilateral occlusion of the intracranial internal cerebral arteries (ICA) and their …
spontaneous bilateral occlusion of the intracranial internal cerebral arteries (ICA) and their …
Moyamoya disease emerging as an immune-related angiopathy
C Asselman, D Hemelsoet, D Eggermont… - Trends in Molecular …, 2022 - cell.com
Moyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. MMD
is characterized by progressive narrowing of arteries of the brain and the formation of a …
is characterized by progressive narrowing of arteries of the brain and the formation of a …
[HTML][HTML] Epidemiology, diagnosis and treatment of moyamoya disease
H Zhang, L Zheng, L Feng - Experimental and …, 2019 - spandidos-publications.com
Moyamoya disease (MMD) is a type of chronic cerebrovascular occlusion disease, which
frequently occurs in East Asian populations, including pediatric and adult patients, and may …
frequently occurs in East Asian populations, including pediatric and adult patients, and may …
European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular european reference network (VASCERN)
The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA),
developed according to ESO standard operating procedure and Grading of …
developed according to ESO standard operating procedure and Grading of …
The AAA+ ATPase/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets
M Sugihara, D Morito, S Ainuki, Y Hirano… - Journal of Cell …, 2019 - rupress.org
Mysterin, also known as RNF213, is an intracellular protein that forms large toroidal
oligomers. Mysterin was originally identified in genetic studies of moyamoya disease (MMD) …
oligomers. Mysterin was originally identified in genetic studies of moyamoya disease (MMD) …
RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability
Y Mineharu, S Miyamoto - Frontiers in Neurology, 2021 - frontiersin.org
Moyamoya disease is an idiopathic chronically progressive cerebrovascular disease, which
causes both ischemic and hemorrhagic stroke. Genetic studies identified RNF213/Mysterin …
causes both ischemic and hemorrhagic stroke. Genetic studies identified RNF213/Mysterin …
Novel multifaceted roles for RNF213 protein
G Pollaci, G Gorla, A Potenza, T Carrozzini… - International Journal of …, 2022 - mdpi.com
Ring Finger Protein 213 (RNF213), also known as Mysterin, is the major susceptibility factor
for Moyamoya Arteriopathy (MA), a progressive cerebrovascular disorder that often leads to …
for Moyamoya Arteriopathy (MA), a progressive cerebrovascular disorder that often leads to …
Recognition of phylogenetically diverse pathogens through enzymatically amplified recruitment of RNF213
A Crespillo-Casado, P Pothukuchi, K Naydenova… - EMBO …, 2024 - embopress.org
Innate immunity senses microbial ligands known as pathogen-associated molecular
patterns (PAMPs). Except for nucleic acids, PAMPs are exceedingly taxa-specific, thus …
patterns (PAMPs). Except for nucleic acids, PAMPs are exceedingly taxa-specific, thus …
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
C Vilariño-Güell, A Zimprich, F Martinelli-Boneschi… - PLoS …, 2019 - journals.plos.org
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system
characterized by myelin loss and neuronal dysfunction. Although the majority of patients do …
characterized by myelin loss and neuronal dysfunction. Although the majority of patients do …